One of the things I love most about writing to you all is the messages I get from traders who are living through the real, messy, complicated process of becoming who they need to be. This letter below landed in my inbox recently from a member of...

There were no S&P 500 earnings reactions on Friday, but we want to highlight a healthcare name that has our attention.

Penumbra $PEN is a $12B medical devices company sitting at the center of one of the most important growth markets in...

Sign up for my free daily note here.

Energy is quietly setting up for its next major move...

Last year, international stocks finally outperformed the United States. And we think this continues.

Just last week, Europe $VGK eclipsed its pre-financial crisis highs and is trading at all time highs for the first...

Sunday Stalk List | Ep. 30

Welcome back to The Sunday Stalk List.

Every weekend, I review hundreds if not thousands of charts across U.S. indices, global markets, breadth, sentiment, and intermarket relationships.

And now I’m opening...

Earnings are the heartbeat of the market, and every week brings a fresh set of opportunities and risks. 

With each report, we get new information on corporate health, investor sentiment, and where money is rotating.

In the ...